Development of New Software Capabilities for Use With Cardiovascular Magnetic Resonance Imaging (CVMRI)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Michael Buonocore, MD, PhD, University of California, Davis
ClinicalTrials.gov Identifier:
NCT00593541
First received: January 3, 2008
Last updated: October 30, 2012
Last verified: October 2012

January 3, 2008
October 30, 2012
May 1999
January 2015   (final data collection date for primary outcome measure)
Extend or generalize certain capabilities, such as new data acquisition pulse sequences, new image processing and analysis software for structural and functional analysis of the MR images [ Time Frame: Post-scanning ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00593541 on ClinicalTrials.gov Archive Site
Improve image quality by various techniques (e.g. reducing the effects of motion) [ Time Frame: Post-scanning ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Development of New Software Capabilities for Use With Cardiovascular Magnetic Resonance Imaging
Development of New Software Capabilities for Use With Cardiovascular Magnetic Resonance Imaging

This Protocol is intended to facilitate development and testing of new cardiovascular MRI software capabilities by UC Davis Research Faculty, as well as to facilitate the evaluation of new software capabilities provided by GE and Siemens.

This protocol will permit normal subjects, as well as patients with suspected or proven medical conditions, to undergo MRI studies using the new software capabilities. This Protocol is not restricted to imaging of a particular organ system or disease. The Protocol does not involve injection of any contrast agent, or other minimally-invasive or invasive procedure. It is intended only for those cases for which the only requirement of the subject is to relax and lie still while imaging is being performed.

Observational
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Noraml volunteers and patients with known or suspected cardiovascular disease

Abnormalities, Cardiovascular
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
120
January 2015
January 2015   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • 18 years of age or older
  • Ability to give informed, written consent
  • Not Pregnant or breastfeeding

Exclusion Criteria:

  • Electrically, magnetically, or mechanically activated implants (for example, cardiac-pacemakers)
  • Ferromagnetic implant, such as an aneurysm clip, surgical clip, or prosthesis
  • History of uncontrolled claustrophobia
Both
18 Years and older
Yes
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
NCT00593541
200210689
No
Michael Buonocore, MD, PhD, University of California, Davis
Michael Buonocore, MD, PhD
Not Provided
Principal Investigator: Michael H Buonocore, MD, PhD University of California, Davis
University of California, Davis
October 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP